Henry J Fuchs - Net Worth and Insider Trading
Henry J Fuchs Net Worth
The estimated net worth of Henry J Fuchs is at least $18 Million dollars as of 2024-04-26. Henry J Fuchs is the President, Worldwide R&D of Biomarin Pharmaceutical Inc and owns about 212,117 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $17 Million. Henry J Fuchs is also the Director of Mirati Therapeutics Inc and owns about 6,021 shares of Mirati Therapeutics Inc (MRTX) stock worth over $353,433. Details can be seen in Henry J Fuchs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Henry J Fuchs has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Henry J Fuchs
Henry J Fuchs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry J Fuchs owns 2 companies in total, including Mirati Therapeutics Inc (MRTX) , and Biomarin Pharmaceutical Inc (BMRN) .
Click here to see the complete history of Henry J Fuchs’s form 4 insider trades.
Insider Ownership Summary of Henry J Fuchs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2022-02-11 | director |
| BMRN | Biomarin Pharmaceutical Inc | 2024-03-05 | Chief Medical Officer |
Henry J Fuchs Latest Holdings Summary
Henry J Fuchs currently owns a total of 2 stocks. Among these stocks, Henry J Fuchs owns 212,117 shares of Biomarin Pharmaceutical Inc (BMRN) as of March 5, 2024, with a value of $17 Million and a weighting of 98.01%. Henry J Fuchs also owns 6,021 shares of Mirati Therapeutics Inc (MRTX) as of February 11, 2022, with a value of $353,433 and a weighting of 1.99%.
Latest Holdings of Henry J Fuchs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2024-03-05 | 212,117 | 82.17 | 17,429,654 |
| MRTX | Mirati Therapeutics Inc | 2022-02-11 | 6,021 | 58.70 | 353,433 |
Holding Weightings of Henry J Fuchs
Henry J Fuchs Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry J Fuchs has made a total of 6 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 35,341 shares on March 5, 2024, which brought Henry J Fuchs around $3 Million.
According to the SEC Form 4 filings, Henry J Fuchs has made a total of 3 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 11,000 shares on February 11, 2022, which brought Henry J Fuchs around $1 Million.
Insider Trading History of Henry J Fuchs
- 1
Henry J Fuchs Trading Performance
Henry J Fuchs Ownership Network
Ownership Network List of Henry J Fuchs
Ownership Network Relation of Henry J Fuchs
Henry J Fuchs Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Henry J Fuchs is the director of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Henry J Fuchs made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Henry J Fuchs Mailing Address
Above is the net worth, insider trading, and ownership report for Henry J Fuchs. You might contact Henry J Fuchs via mailing address: C/o Biomarin Pharmaceutical Inc., 105 Digital Drive, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
